Back to search
FDAFDA · Food and drugs·Recall number D-0013-2015

Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1

Published October 15, 2014 · Recall initiated: September 30, 2014

Summary

FDA records drug Class III recall D-0013-2015, published October 15, 2014 and initiated September 30, 2014. Recalling firm: Gilead Sciences, Inc.; Status: Terminated; Reported quantity: 10,317 bottles; Lot: TRUVADA (NDA 21-752; NDC 61958-0701-1) Lot# 002808, Expiration Date: 31 December 2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.

What to do

Voluntary: Firm initiated · Letter

Get an email if TRUVADA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TRUVADA
Manufacturer
Gilead Sciences, Inc.
Distributor
Nationwide
Lot
TRUVADA (NDA 21-752; NDC 61958-0701-1) Lot# 002808, Expiration Date: 31 December 2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1 recalled?

Yes. FDA published recall D-0013-2015 on October 15, 2014. Reported hazard: Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TRUVADA.